FI752572A - - Google Patents

Info

Publication number
FI752572A
FI752572A FI752572A FI752572A FI752572A FI 752572 A FI752572 A FI 752572A FI 752572 A FI752572 A FI 752572A FI 752572 A FI752572 A FI 752572A FI 752572 A FI752572 A FI 752572A
Authority
FI
Finland
Application number
FI752572A
Other languages
Finnish (fi)
Other versions
FI64352C (fi
FI64352B (fi
Inventor
Ronald Leslie Buchanan
Alex Michael Jelenevsky
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI752572A publication Critical patent/FI752572A/fi
Application granted granted Critical
Publication of FI64352B publication Critical patent/FI64352B/fi
Publication of FI64352C publication Critical patent/FI64352C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI752572A 1974-09-18 1975-09-15 Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-ndo-(3-indolkarbonyloxi)-n-(amino(laegre)alkyl)bicyklo-(2 .21)heptan-2,3-di-endokarboxylsyraimider FI64352C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50702974A 1974-09-18 1974-09-18
US50702974 1974-09-18
US59491875 1975-07-10
US05/594,918 US3980668A (en) 1974-09-18 1975-07-10 Anti-arrhythimic 5-endo-(3-indolecarbonyloxy)-N-[amino-(lower)alkyl]bicyclo[2,2,1]heptane-2,3-di-endo-carboxylic acid imides

Publications (3)

Publication Number Publication Date
FI752572A true FI752572A (no) 1976-03-19
FI64352B FI64352B (fi) 1983-07-29
FI64352C FI64352C (fi) 1983-11-10

Family

ID=27055675

Family Applications (1)

Application Number Title Priority Date Filing Date
FI752572A FI64352C (fi) 1974-09-18 1975-09-15 Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-ndo-(3-indolkarbonyloxi)-n-(amino(laegre)alkyl)bicyklo-(2 .21)heptan-2,3-di-endokarboxylsyraimider

Country Status (24)

Country Link
US (1) US3980668A (no)
JP (1) JPS6039669B2 (no)
AR (1) AR212235A1 (no)
AT (1) AT345275B (no)
CA (1) CA1068281A (no)
CH (1) CH615925A5 (no)
CS (1) CS187489B2 (no)
DD (1) DD123092A5 (no)
DE (1) DE2541434A1 (no)
DK (1) DK418075A (no)
ES (2) ES441038A1 (no)
FI (1) FI64352C (no)
FR (1) FR2313047A1 (no)
GB (1) GB1484214A (no)
HU (1) HU173807B (no)
IE (1) IE42051B1 (no)
IL (1) IL48096A (no)
LU (1) LU73418A1 (no)
NL (1) NL7510934A (no)
NO (1) NO144072C (no)
PH (1) PH11498A (no)
PL (2) PL101454B1 (no)
SE (1) SE421421B (no)
YU (2) YU40123B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557341A1 (de) * 1975-12-19 1977-06-30 Hoechst Ag Basisch substituierte indolderivate und verfahren zu ihrer herstellung
US4139533A (en) * 1976-08-19 1979-02-13 Bristol-Myers Company Bicyclo[2,2,1]heptane-2,3-diendo carboxylic acid imide esters of quinoline carboxylic acid
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3850921A (en) * 1972-09-20 1974-11-26 I Matuo Derivatives of 2,3-norbornanedicarboxamide

Also Published As

Publication number Publication date
YU40123B (en) 1985-08-31
YU284082A (en) 1985-04-30
IL48096A (en) 1979-09-30
NO144072B (no) 1981-03-09
ES441038A1 (es) 1977-07-01
LU73418A1 (no) 1976-08-13
PL101454B1 (pl) 1978-12-30
NL7510934A (nl) 1976-03-22
SE7510362L (sv) 1976-03-19
IL48096A0 (en) 1975-11-25
AR212235A1 (es) 1978-06-15
CH615925A5 (no) 1980-02-29
ES455938A1 (es) 1978-02-01
IE42051B1 (en) 1980-05-21
GB1484214A (en) 1977-09-01
CS187489B2 (en) 1979-01-31
HU173807B (no) 1979-08-28
DD123092A5 (no) 1976-11-20
US3980668A (en) 1976-09-14
ATA718575A (de) 1978-01-15
NO144072C (no) 1981-06-17
CA1068281A (en) 1979-12-18
PH11498A (en) 1978-02-01
NO753128L (no) 1976-03-19
DK418075A (da) 1976-03-19
FR2313047B1 (no) 1979-09-14
FI64352C (fi) 1983-11-10
IE42051L (en) 1976-03-18
JPS51131871A (en) 1976-11-16
YU225375A (en) 1983-12-31
AU8459775A (en) 1977-03-10
DE2541434A1 (de) 1976-04-08
AT345275B (de) 1978-09-11
JPS6039669B2 (ja) 1985-09-06
SE421421B (sv) 1981-12-21
FR2313047A1 (fr) 1976-12-31
FI64352B (fi) 1983-07-29
PL100522B1 (pl) 1978-10-31

Similar Documents

Publication Publication Date Title
FR2269599A1 (no)
JPS5112557B2 (no)
JPS5115348U (no)
FR2313047B1 (no)
JPS50136752A (no)
JPS50123601A (no)
HU169259B (no)
JPS50157456U (no)
CS167207B2 (no)
CH580740A5 (no)
CH576579A5 (no)
CH583032A5 (no)
CH583017A5 (no)
CH582789A5 (no)
CH582457A5 (no)
CH583746A5 (no)
CH581272A5 (no)
CH606782A5 (no)
BG20849A1 (no)
CH581010A5 (no)
CH579456A5 (no)
CH580353A5 (no)
BG20724A1 (no)
CH578156A5 (no)
CH577577A5 (no)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BRISTOL-MYERS CO